A review of barriers and facilitators to mammography in Asian women

Abstract

Aim: Breast cancer is the most common cancer among women in Asia and one of the major health problems in most countries in the region. Despite extensive advances in treatment, early diagnosis is one of the main methods for increasing the survival rate. It is necessary to evaluate the barriers and facilitators of screening in different societies. This study was conducted to identify the barriers and facilitators of mammography in Asia. Materials and methods: To identify the barriers and facilitators of mammography in Asia, a comprehensive search was carried out in databases such as Medline, Web of Science Core Collection and Scopus using keywords, including breast cancer, screening, mammography, barriers, facilitators and the names of each Asian country, as well as a combination of these keywords were used to help the search. Full-text, English language and original articles were included in this study. Results: In total, 71 articles were entered into the study. The findings of this study revealed various barriers to mammography in Asian women, including knowledge, sociodemographic factors, cost and insurance, cultural factors, belief, attitude and feeling, fear, pain and embarrassment, self-efficacy, religious, psychological factors, time constraint, fatalism, professional recommendations, communication, social support and access. Also, knowledge, attitude and belief, perceived risk, professional and social factors were found to be facilitators of mammography. Conclusion: Knowing the barriers and facilitators to access mammography is the first step in the development of a successful screening program. Awareness and various personal, professional and social factors have emerged as the major barriers to access to mammography in most Asian countries.

Determinants of Intention to Participate in Breast Cancer Screening among Urban Chinese Women: An Application of the Protection Motivation Theory

“…A lack of knowledge and unawareness of the necessity of screening is a significant barrier to widespread participation in mammography screening [ 12 , 13 ]. Other factors that affect the screening uptake include education level, occupation, a personal history of breast disease, cost and time constraint, fear, and embarrassment [ 14 , 15 , 16 , 17 , 18 , 19 , 20 ].…”

ML323 suppresses the progression of ovarian cancer via regulating USP1-mediated cell cycle

“…Ovarian cancer (OV) is the most lethal gynecological carcinoma, occupying the second mortality among women globally (Siegel et al, 2019). Despite considerable advancements in current surgical and chemotherapy treatment, the prognosis for ovarian cancer patients remains unfavorable, with a 5-years overall survival rate of less than 45% (Momenimovahed et al, 2019). (Simone et al, 2016), duing to its rapid tumor progression, metastasis, and limited therapeutic strategies (Torre et al, 2018).…”

2-Dimensional in vitro culture assessment of ovarian cancer cell line using cost effective silver nanoparticles from Macrotyloma uniflorum seed extracts

“…Ovarian cancer is the world's second most prevalent gynaecological malignancy, and the fifth most common cancer overall (Momenimovahed et al, 2019). Obesity and overweight, gynaecological surgery, hormone therapy, breast cancer, age, family history, reproductive history, human, talcum powder, and HPV are all variables that increase the risk of ovarian cancer (Ebell et al, 2016).…”